Glenmark Pharma ex-dividend Oct. 3, 2025, with ₹2.50 interim payout, amid profit drop and U.S. tariff concerns.

Glenmark Pharmaceuticals will trade ex-dividend on October 3, 2025, with an interim dividend of ₹2.50 per share payable to shareholders on the record date. Despite a sharp year-on-year drop in net profit and a slight revenue decline, the company reported strong EBITDA margins. The stock has seen modest gains over recent months, though it faces broader sector challenges due to anticipated U.S. tariffs on branded drugs starting October 1. Other companies, including Paushak Ltd and GEE Ltd, are implementing bonus issues and stock splits, while several firms are conducting capital reductions, right issues, or suspending trading. These corporate actions are scheduled from September 29 to October 3, 2025.